Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity

Chagas disease is included in the neglected tropical diseases list and is endemic to 21 Latin American countries. The two drugs currently available for treating Chagas disease are nifurtimox and benznidazole and both result in many significant side effects. The study describes the synthesis and biological evaluation of 3,5-disubstituted isoxazoles. Isoxazoles were obtained by reaction of flavones and hydroxylamine and either alkylated at the free hydroxyl group and/or nitrated at the isoxazole ring. These compounds were evaluated for their in vitro anti-Trypanosoma cruzi activity against trypomastigote and amastigote forms of the parasite in T. cruzi-infected cell lineages. Benznidazole was used as a reference compound for the in vitro assay and mammalian L929 cells were employed to evaluate cytotoxicity. A majority of the compounds tested were very active and the most active isoxazole against amastigote and trypomastigotes of T. cruzi was slightly more potent than the current medicine benznidazole.

Saved in:
Bibliographic Details
Main Authors: Souza,Aline A. N. de, Xavier,Viviane F., Coelho,Gleicekelly S., Sales Junior,Policarpo A., Romanha,Alvaro J., Murta,Silvane M. F., Carneiro,Claudia M., Taylor,Jason G.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Química 2018
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532018000200269
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0103-50532018000200269
record_format ojs
spelling oai:scielo:S0103-505320180002002692018-02-09Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal ActivitySouza,Aline A. N. deXavier,Viviane F.Coelho,Gleicekelly S.Sales Junior,Policarpo A.Romanha,Alvaro J.Murta,Silvane M. F.Carneiro,Claudia M.Taylor,Jason G. isoxazole azole amastigote trypomastigote in vitro Chagas disease Chagas disease is included in the neglected tropical diseases list and is endemic to 21 Latin American countries. The two drugs currently available for treating Chagas disease are nifurtimox and benznidazole and both result in many significant side effects. The study describes the synthesis and biological evaluation of 3,5-disubstituted isoxazoles. Isoxazoles were obtained by reaction of flavones and hydroxylamine and either alkylated at the free hydroxyl group and/or nitrated at the isoxazole ring. These compounds were evaluated for their in vitro anti-Trypanosoma cruzi activity against trypomastigote and amastigote forms of the parasite in T. cruzi-infected cell lineages. Benznidazole was used as a reference compound for the in vitro assay and mammalian L929 cells were employed to evaluate cytotoxicity. A majority of the compounds tested were very active and the most active isoxazole against amastigote and trypomastigotes of T. cruzi was slightly more potent than the current medicine benznidazole.info:eu-repo/semantics/openAccessSociedade Brasileira de QuímicaJournal of the Brazilian Chemical Society v.29 n.2 20182018-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532018000200269en10.21577/0103-5053.20170137
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Souza,Aline A. N. de
Xavier,Viviane F.
Coelho,Gleicekelly S.
Sales Junior,Policarpo A.
Romanha,Alvaro J.
Murta,Silvane M. F.
Carneiro,Claudia M.
Taylor,Jason G.
spellingShingle Souza,Aline A. N. de
Xavier,Viviane F.
Coelho,Gleicekelly S.
Sales Junior,Policarpo A.
Romanha,Alvaro J.
Murta,Silvane M. F.
Carneiro,Claudia M.
Taylor,Jason G.
Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity
author_facet Souza,Aline A. N. de
Xavier,Viviane F.
Coelho,Gleicekelly S.
Sales Junior,Policarpo A.
Romanha,Alvaro J.
Murta,Silvane M. F.
Carneiro,Claudia M.
Taylor,Jason G.
author_sort Souza,Aline A. N. de
title Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity
title_short Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity
title_full Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity
title_fullStr Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity
title_full_unstemmed Synthesis of 3,5-Diarylisoxazole Derivatives and Evaluation of in vitro Trypanocidal Activity
title_sort synthesis of 3,5-diarylisoxazole derivatives and evaluation of in vitro trypanocidal activity
description Chagas disease is included in the neglected tropical diseases list and is endemic to 21 Latin American countries. The two drugs currently available for treating Chagas disease are nifurtimox and benznidazole and both result in many significant side effects. The study describes the synthesis and biological evaluation of 3,5-disubstituted isoxazoles. Isoxazoles were obtained by reaction of flavones and hydroxylamine and either alkylated at the free hydroxyl group and/or nitrated at the isoxazole ring. These compounds were evaluated for their in vitro anti-Trypanosoma cruzi activity against trypomastigote and amastigote forms of the parasite in T. cruzi-infected cell lineages. Benznidazole was used as a reference compound for the in vitro assay and mammalian L929 cells were employed to evaluate cytotoxicity. A majority of the compounds tested were very active and the most active isoxazole against amastigote and trypomastigotes of T. cruzi was slightly more potent than the current medicine benznidazole.
publisher Sociedade Brasileira de Química
publishDate 2018
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0103-50532018000200269
work_keys_str_mv AT souzaalineande synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT xaviervivianef synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT coelhogleicekellys synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT salesjuniorpolicarpoa synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT romanhaalvaroj synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT murtasilvanemf synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT carneiroclaudiam synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
AT taylorjasong synthesisof35diarylisoxazolederivativesandevaluationofinvitrotrypanocidalactivity
_version_ 1756403719394557952